1,617
Participants
Start Date
December 29, 2019
Primary Completion Date
October 31, 2020
Study Completion Date
October 31, 2020
Tiotropium + Olodaterol
Spiolto®
Other LABA/LAMA
tiotropium/olodaterol, indacaterol/glycopyrronium, vilanterol/umeclidinium
LAMA
aclidinium bromide, glycopyrronium, tiotropium, umeclidinium
National Taiwan University hospital, Taipei
Makay memorial hospital, Taipei
Cheng Hsin general hospital, Taipei
Far east memorial hospital, New Taipei City
Taipei Tzu Chi hospital, Taipei
CGMH Linkou, Taoyuan
China medicine memorial hospital, Taichung
VGH Taichung, Taichung
Ditmanson Medical Foundation Chia - Yi Christian Hospital, Chia YI City
CGMH Chia YI, Chia YI City
Eda hospital, Kaohsiung City
CGMH Kaohsiung, Kaohsiung City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY